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cytomegalovirus and BK virusDear Editor,
Hypereosinophilia (i.e. a blood eosinophil count exceeding
1.5  109/L) can be caused by various triggers including numerous
allergic, infectious, and neoplastic disorders, and intrinsically cause
tissue and organ damage, regardless of underlying cause. Drug re-
action with eosinophilia and systemic symptoms (DRESS)
syndrome/drug-induced hypersensitivity syndrome (DIHS) is a
rare, potentially life-threatening adverse drug-induced reaction
with cutaneous manifestations and internal organ involvement.1,2
Reactivation of herpesviruses, including human herpesvirus-6
(HHV-6), HHV-7, cytomegalovirus (CMV), and EpsteineBarr virus
(EBV), has been shown to play a role in DRESS/DIHS pathogen-
esis.2,3 Here, we report an infant case with severe hypereosino-
philia accompanied by cutaneous, cardiac, and pulmonary
manifestations, and reactivation of CMV and BK virus (BKV).
A previously healthy 17-month-old girl was referred to our insti-
tute on the 2nd day of illness because of high-grade fever and skin
eruption. The patient had a cough and low-grade fever, and thus
received pranlukast and azithromycin (AZM) from ten days and
four days before the visit, respectively. The patient had no history
of allergies, but had a family history of drug allergy. On admission,
her temperature was 38.8 C; blood pressure, 108/62; heart rate,
180; respiratory rate, 38; and oxygen saturation, 94% in room air.
Reticulated erythema spread from trunk to extremities, but not
intomucosa and conjunctivas. Physical examination revealed cervi-
cal lymphadenopathy without hepatosplenomegaly. Laboratory
ﬁndings revealed leukocytosis and eosinophilia with white blood
cell count of 39.8  109/L with 54% eosinophils (21.5  109/L),
20% neutrophils, 21% lymphocytes, and 1.0% atypical lymphocytes.
The blood chemistry results including hepatic enzymes were not
notable. Immunoglobulin G, A, M and E were within the age-
matched normal range. Pathogens were not isolated from blood,
urine, or stool culture. Rapid antigen tests for respiratory syncytial
virus, mycoplasma, and adenovirus were negative. Serologic tests
revealed absence of active infection of CMV, EBV, humanparvovirus
Bl9 (hPV-B19), human immunodeﬁciency virus, hepatitis viruses,
and HHV-6.
Pneumonia was observed on the chest radiograph, and deterio-
rated with progression of desaturation, in spite of treatment with
ampicillin/sulbactam. A chest computed tomography scan on the
4th hospital day revealed a mixture of ground-glass opacities andPeer review under responsibility of Japanese Society of Allergology.
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more, an echocardiography revealed myocardial hypertrophy:
IVSd, 7.9 mm (5.07 SD); LVIDd, 27.0 mm (0.40 SD); LVPWd,
7.3 mm (4.77 SD); LVIDs, 15.9 mm (0.10 SD); and EF, 79.6%. Serum
NT-proBNP was elevated: 1334 pg/mL [<125 pg/mL], but neither
TnT nor CK-MB. Skin biopsy revealed evidence of eosinophilic inﬁl-
tration into subcutaneous tissue without vasculitis. These results
indicated multiple organ failure with hypereosinophilia.
Bone marrow examination revealed normocellular bone
marrow with eosinophil proliferation (26.2%) but not immature
or monoclonal cell proliferation, which indicated the absence of
myeloproliferative neoplasms.4 Primary hypereosinophilic
syndrome-associated gene analysis, including FISH and RT-PCR of
the FIP1L1-PDGFRA fusion gene and direct sequencing of PDGFRA
and PDGFRB, were negative. Anti-nuclear and anti-neutrophil cyto-
plasmic antibodies were negative. Parasite examination of stool
was negative. Serologic and sputum tests for Aspergilluswere nega-
tive. There was no elevation of serum beta-D glucan. Multiplex PCR
analysis for viral DNA of whole blood samples detected CMV and
BKV DNA on the 2nd hospital day (52 copies/mL and 32 copies/
mL, respectively), which increased on day 32 (1.0  103 copies/
mL and 37 copies/mL, respectively). On the 4th day, lymphocyte
transformation test (LTT) for pranlukast and AZM were positive
(2.31 and 2.16 [stimulation index: <1.81], respectively).
The patient was treated with administration of prednisolone
(2mg/kg/day) from the 6th day, and her symptoms, including fever,
skin eruption, and desaturation, markedly improved on the next
day. Hypereosinophilia also improved (0/L; leukocyte count,
9.5  109/L) on the 9th day and did not relapse through tapering
and withdrawal of prednisolone (Fig. 2A). Systemic corticosteroid
therapy rapidly improved pneumonia and gradually improved
myocardial hypertrophy; thus, the patient left the hospital on the
28th day. However, pulmonary arterial hypertension persisted
and required treatmentwith sildenaﬁl from 33 days after discharge.
Cardiac catheterization revealed pulmonary arterial hypertension
one month after discharge: mean pulmonary artery pressure
(PAP), 45 mmHg [<25 mmHg]; pulmonary vascular resistance
(Rp), 11.61 Um2; pulmonary artery wedge pressure (PAWP),
9 mmHg; systemic blood ﬂow (Qs), 3.10 L/min/m2, and improve-
ment of that after four months: PAP, 28 mmHg; Rp, 2.79 Um2;
PAWP, 11 mmHg; Qs, 5.74 L/min/m2.
In this case, systemic corticosteroid therapy rapidly improved
hypereosinophilia accompanied with improvement of associated
manifestations, thus that therapeutic response and transientvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1. Chest computed tomography scan on the 14th day. A mixture of ground-glass
opacities (white arrows) in the both lobes and nodular shadows (white arrowhead)
in the right lobe with hilar lymphadenopathy.
Fig. 2. Treatment progress. A. Change in the number of leukocytes and eosinophils.
mPSL, methylprednisolone. B. Progress of viral DNA loads and anti-viral antibody titers.
BKV, BK virus; CMV, cytomegalovirus; HHV, human herpesvirus. Methods: EIA,
enzyme immunoassay; FA, ﬂuorescent antibody.
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with hypereosinophilia. Investigation of the cause of hypereosino-
philia denied infections, hematologic/neoplastic disorders, and im-
mune dysregulation,4 however LTT was positive. The RegiSCAR
scoring system for classifying DRESS1 indicated “deﬁnite”, but the
clinical course might be atypical for DRESS. Typically, DRESS has a
late onset, 2e6 weeks after use of the culprit drug1 and a retrospec-
tive study showed that the average interval time to drug reaction
was 20.7 days (range, 3e76 days).5 In this case, latency period be-
tween drug exposure and onset of symptoms was 3 and 8 days,Please cite this article in press as: Kobayashi A, et al., An infant case of s
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DRESS/DIHS were previously reported and these cases had relative
short latency period (7e10 days).6 Furthermore, it was suggested
that DRESS/DIHS might be correlated with multiple drug hypersen-
sitivity (MDH).7 Therefore, we speculated that DRESS of this patient
might be associated with MDH to AZM and pranlukast, although a
possibility of non-speciﬁc reactions could not deny completely.
It was suggested that imbalance and abnormal proliferation of
regulatory T cells would lead to eosinophilia, and expansion of reg-
ulatory T cells would occur far before DRESS/DIHS onset, which
would contribute to reactivations of herpes viruses.3 Sequential
reactivations of various herpesviruses have exclusively been
demonstrated during the acute stage of DRESS/DIHS as with
graft-versus-host diseases (GVHD).3 Our multiplex PCR system
covered herpes simplex virus, HHV-6, -7, and -8, varicella-zoster vi-
rus, CMV, EBV, hPV-Bl9, JC virus, and BKV.8 Interestingly, in this
case, CMV and BKV, but not HHV-6, were detected. Thus, we sero-
logically conﬁrmed that the patient had a past infection of CMV but
not HHV-6, which might be the cause of lack of HHV-6 reactivation.
BKV, which is a member of the polyomavirus family, infects most
people subclinically during early childhood and, in most immuno-
competent individuals, the infection is completely asymptomatic,
however, in immunocompromised patients including hematopoi-
etic bone marrow transplant and kidney transplant patients/recip-
ients, BKV reactivation followed by high-level viral replication
could cause hemorrhagic cystitis and nephropathy.9 BKV reactiva-
tion was observed in patients with immunodeﬁciency or GVHD,9
furthermore, it was reported that active HHV6 reactivation might
be associated with GVHD and co-reactivations of CMV and BKV.10
In this case, slight elevation of BKV DNA loads might lead to asymp-
tomatic course, however BKV reactivation might support the hy-
pothesis regarding clinical and immunological similarity between
DRESS/DIHS and GVHD.5 The elevation of viral DNA loads, which
indicated CMV and BKV viremias, spontaneously faded out after
several months without a speciﬁc therapy (Fig. 2B).
In conclusion, we report an infant case of severe hypereosino-
philia and systemic symptoms with MDH for AZM and pranlukast
associated with reactivation of cytomegalovirus and BK virus. LTT
and multiplex virus PCR were used to diagnose DRESS, and our
case might provide novel insight regarding BKV reactivation in
DRESS/DIHS.
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